Please assess the completion status of the following clinical trial:

Trial Title: Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patient (male or female) requiring emergency endotracheal intubation.~Exclusion Criteria:~* Children (\<18 years old).~* Women who are known to be pregnant.~* Any patient who has been previously randomized in the EvK Trial.~* Patients who require endotracheal intubation without sedative medication. For example, patients in full cardiac arrest.~* Patients with a known allergy to ketamine or etomidate.~* Any individual wearing a MedAlert bracelet indicating that he/she has formally opted out of the EvK Trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Etomidate (Type: EXPERIMENTAL): Patients randomized to this group will receive etomidate immediately prior to emergency endotracheal intubation.
- Ketamine (Type: EXPERIMENTAL): Patients randomized to this group will receive ketamine immediately prior to emergency endotracheal intubation.

Based on this trial design, predict the completion outcome and termination type (if applicable).